2024-04-012025-03-312025-03-31false04683350CORALBERRY LIMITED2025-11-1947730falseiso4217:GBPxbrli:pure046833502024-03-31046833502025-03-31046833502024-04-012025-03-31046833502023-03-31046833502024-03-31046833502023-04-012024-03-3104683350bus:SmallEntities2024-04-012025-03-3104683350bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3104683350bus:FullAccounts2024-04-012025-03-3104683350bus:PrivateLimitedCompanyLtd2024-04-012025-03-3104683350core:WithinOneYear2025-03-3104683350core:AfterOneYear2025-03-3104683350core:WithinOneYear2024-03-3104683350core:AfterOneYear2024-03-3104683350core:ShareCapital2025-03-3104683350core:SharePremium2025-03-3104683350core:RevaluationReserve2025-03-3104683350core:OtherReservesSubtotal2025-03-3104683350core:RetainedEarningsAccumulatedLosses2025-03-3104683350core:ShareCapital2024-03-3104683350core:SharePremium2024-03-3104683350core:RevaluationReserve2024-03-3104683350core:OtherReservesSubtotal2024-03-3104683350core:RetainedEarningsAccumulatedLosses2024-03-3104683350core:LandBuildings2025-03-3104683350core:PlantMachinery2025-03-3104683350core:Vehicles2025-03-3104683350core:FurnitureFittings2025-03-3104683350core:OfficeEquipment2025-03-3104683350core:NetGoodwill2025-03-3104683350core:IntangibleAssetsOtherThanGoodwill2025-03-3104683350core:ListedExchangeTraded2025-03-3104683350core:UnlistedNon-exchangeTraded2025-03-3104683350core:LandBuildings2024-03-3104683350core:PlantMachinery2024-03-3104683350core:Vehicles2024-03-3104683350core:FurnitureFittings2024-03-3104683350core:OfficeEquipment2024-03-3104683350core:NetGoodwill2024-03-3104683350core:IntangibleAssetsOtherThanGoodwill2024-03-3104683350core:ListedExchangeTraded2024-03-3104683350core:UnlistedNon-exchangeTraded2024-03-3104683350core:LandBuildings2024-04-012025-03-3104683350core:PlantMachinery2024-04-012025-03-3104683350core:Vehicles2024-04-012025-03-3104683350core:FurnitureFittings2024-04-012025-03-3104683350core:OfficeEquipment2024-04-012025-03-3104683350core:NetGoodwill2024-04-012025-03-3104683350core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3104683350core:ListedExchangeTraded2024-04-012025-03-3104683350core:UnlistedNon-exchangeTraded2024-04-012025-03-3104683350core:MoreThanFiveYears2024-04-012025-03-3104683350core:Non-currentFinancialInstruments2025-03-3104683350core:Non-currentFinancialInstruments2024-03-3104683350dpl:CostSales2024-04-012025-03-3104683350dpl:DistributionCosts2024-04-012025-03-3104683350core:LandBuildings2024-04-012025-03-3104683350core:PlantMachinery2024-04-012025-03-3104683350core:Vehicles2024-04-012025-03-3104683350core:FurnitureFittings2024-04-012025-03-3104683350core:OfficeEquipment2024-04-012025-03-3104683350dpl:AdministrativeExpenses2024-04-012025-03-3104683350core:NetGoodwill2024-04-012025-03-3104683350core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3104683350dpl:GroupUndertakings2024-04-012025-03-3104683350dpl:ParticipatingInterests2024-04-012025-03-3104683350dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3104683350core:ListedExchangeTraded2024-04-012025-03-3104683350dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3104683350core:UnlistedNon-exchangeTraded2024-04-012025-03-3104683350dpl:CostSales2023-04-012024-03-3104683350dpl:DistributionCosts2023-04-012024-03-3104683350core:LandBuildings2023-04-012024-03-3104683350core:PlantMachinery2023-04-012024-03-3104683350core:Vehicles2023-04-012024-03-3104683350core:FurnitureFittings2023-04-012024-03-3104683350core:OfficeEquipment2023-04-012024-03-3104683350dpl:AdministrativeExpenses2023-04-012024-03-3104683350core:NetGoodwill2023-04-012024-03-3104683350core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3104683350dpl:GroupUndertakings2023-04-012024-03-3104683350dpl:ParticipatingInterests2023-04-012024-03-3104683350dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3104683350core:ListedExchangeTraded2023-04-012024-03-3104683350dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3104683350core:UnlistedNon-exchangeTraded2023-04-012024-03-3104683350core:NetGoodwill2025-03-3104683350core:IntangibleAssetsOtherThanGoodwill2025-03-3104683350core:LandBuildings2025-03-3104683350core:PlantMachinery2025-03-3104683350core:Vehicles2025-03-3104683350core:FurnitureFittings2025-03-3104683350core:OfficeEquipment2025-03-3104683350core:AfterOneYear2025-03-3104683350core:WithinOneYear2025-03-3104683350core:ListedExchangeTraded2025-03-3104683350core:UnlistedNon-exchangeTraded2025-03-3104683350core:ShareCapital2025-03-3104683350core:SharePremium2025-03-3104683350core:RevaluationReserve2025-03-3104683350core:OtherReservesSubtotal2025-03-3104683350core:RetainedEarningsAccumulatedLosses2025-03-3104683350core:NetGoodwill2024-03-3104683350core:IntangibleAssetsOtherThanGoodwill2024-03-3104683350core:LandBuildings2024-03-3104683350core:PlantMachinery2024-03-3104683350core:Vehicles2024-03-3104683350core:FurnitureFittings2024-03-3104683350core:OfficeEquipment2024-03-3104683350core:AfterOneYear2024-03-3104683350core:WithinOneYear2024-03-3104683350core:ListedExchangeTraded2024-03-3104683350core:UnlistedNon-exchangeTraded2024-03-3104683350core:ShareCapital2024-03-3104683350core:SharePremium2024-03-3104683350core:RevaluationReserve2024-03-3104683350core:OtherReservesSubtotal2024-03-3104683350core:RetainedEarningsAccumulatedLosses2024-03-3104683350core:NetGoodwill2023-03-3104683350core:IntangibleAssetsOtherThanGoodwill2023-03-3104683350core:LandBuildings2023-03-3104683350core:PlantMachinery2023-03-3104683350core:Vehicles2023-03-3104683350core:FurnitureFittings2023-03-3104683350core:OfficeEquipment2023-03-3104683350core:AfterOneYear2023-03-3104683350core:WithinOneYear2023-03-3104683350core:ListedExchangeTraded2023-03-3104683350core:UnlistedNon-exchangeTraded2023-03-3104683350core:ShareCapital2023-03-3104683350core:SharePremium2023-03-3104683350core:RevaluationReserve2023-03-3104683350core:OtherReservesSubtotal2023-03-3104683350core:RetainedEarningsAccumulatedLosses2023-03-3104683350core:AfterOneYear2024-04-012025-03-3104683350core:WithinOneYear2024-04-012025-03-3104683350core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3104683350core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3104683350core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3104683350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3104683350core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3104683350core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3104683350core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3104683350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3104683350core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3104683350core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3104683350core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3104683350core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3104683350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3104683350core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3104683350core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3104683350core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3104683350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3104683350core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3104683350core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3104683350core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3104683350core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3104683350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3104683350core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3104683350core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3104683350core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3104683350core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3104683350core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3104683350bus:Director12024-04-012025-03-3104683350bus:Director22024-04-012025-03-3104683350core:FurnitureFittingsToolsEquipment2024-03-3104683350core:FurnitureFittingsToolsEquipment2025-03-3104683350core:FurnitureFittingsToolsEquipment2024-04-012025-03-31

CORALBERRY LIMITED

Registered Number
04683350
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

CORALBERRY LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

O'CONNOR, Curtis Luke
O'CONNOR, Glen George

Company Secretary

O'CONNOR, Curtis Luke

Registered Address

Box Pharmacy High Street
Box
Corsham
SN13 8NN

Registered Number

04683350 (England and Wales)
CORALBERRY LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3102,464111,392
102,464111,392
Current assets
Stocks423,82928,494
Debtors5249,862189,243
Cash at bank and on hand1,122673
274,813218,410
Creditors amounts falling due within one year6(246,032)(200,550)
Net current assets (liabilities)28,78117,860
Total assets less current liabilities131,245129,252
Creditors amounts falling due after one year7(19,538)(20,000)
Net assets111,707109,252
Capital and reserves
Called up share capital100100
Profit and loss account111,607109,152
Shareholders' funds111,707109,252
The financial statements were approved and authorised for issue by the Board of Directors on 19 November 2025, and are signed on its behalf by:
O'CONNOR, Curtis Luke
Director
O'CONNOR, Glen George
Director

Registered Company No. 04683350
CORALBERRY LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows: Freehold property - 20 years SL or 5% SL
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20252024
Average number of employees during the year711
3.Tangible fixed assets

Land & buildings

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 April 24198,58937,956888237,433
At 31 March 25198,58937,956888237,433
Depreciation and impairment
At 01 April 2487,19737,956888126,041
Charge for year8,928--8,928
At 31 March 2596,12537,956888134,969
Net book value
At 31 March 25102,464--102,464
At 31 March 24111,392--111,392
4.Stocks

2025

2024

££
Other stocks23,82928,494
Total23,82928,494
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables74,10876,906
Amounts owed by group undertakings139,87870,737
Other debtors35,87641,600
Total249,862189,243
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables102,49394,719
Bank borrowings and overdrafts39,82615,305
Amounts owed to related parties-41,897
Taxation and social security8,6934,896
Other creditors92,75043,733
Accrued liabilities and deferred income2,270-
Total246,032200,550
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
7.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts19,53820,000
Total19,53820,000
8.Directors advances, credits and guarantees
Included in other creditors is an amount of £84,574 (2024: £14,991) relates to the directors' loan account Mr. Curtis O'Connor.
9.Related party transactions
At the year-end, amounts owed by/to group undertakings balance include £139,878 Dr (2024: £70,737) due from New Access (East Anglia) Ltd and £ Nil (2024: £41,897) due to Frampton Pharmacy Ltd, where Mr. Curtis O'Connor and Mr. George G O'Connor are also the directors of those companies.